XML 29 R2.htm IDEA: XBRL DOCUMENT  v2.3.0.11
Consolidated Balance Sheets (USD $)
Jun. 30, 2011
Mar. 31, 2011
ASSETS    
Cash $ 13,417 $ 15,704
Deferred financing costs 109,534 157,732
Note receivable   200,000
Interest receivable   7,096
Prepaid expenses and other current assets 45,227 29,711
Total current assets 168,178 410,243
Property and equipment, net 6,997 7,785
Patents and patents pending, net 137,690 139,981
Deposits 9,210 9,210
Total assets 322,075 567,219
LIABILITIES AND STOCKHOLDERS' DEFICIT    
Accounts payable 331,403 308,413
Due to related parties 656,737 617,570
Notes payable 550,186 190,000
Convertible notes payable, net of discounts 1,996,124 2,181,852
Derivative liabilities 2,221,224 2,002,896
Accrued liquidated damages 437,800 437,800
Other current liabilities 834,122 804,386
Total current liabilities 7,027,596 6,542,917
Commitments and Contingencies (Note 12)    
Common stock, par value $0.001 per share; 250,000,000 shares authorized as of June 30, 2010 and March 31, 2011; 97,237,098 and 77,467,361 shares issued and outstanding as of June 30, 2011 and March 31, 2011, respectively 97,240 77,469
Additional paid-in capital 44,255,086 42,418,778
Deficit accumulated during development stage (51,057,847) (48,471,945)
Total stockholders’ deficit (6,705,521) (5,975,698)
Total liabilities and stockholders' deficit $ 322,075 $ 567,219